Search

Search Constraints

You searched for: Author/Creator Kumar, Alan Prem

Search Results

1. (Nano)platforms in bladder cancer therapy: Challenges and opportunities. Issue 1 (17th June 2022)

2. Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model. Issue 10 (3rd May 2014)

3. Anti-cancer effects of oxymatrine are mediated through multiple molecular mechanism(s) in tumor models. (September 2019)

4. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3. Issue 4 (5th January 2015)

5. Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential. Issue 11 (1st April 2019)

6. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. (October 2016)

7. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. (October 2016)

8. Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy. Issue 1 (13th September 2022)

9. Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28–36]. (28th April 2018)

10. Crocetin imparts antiproliferative activity via inhibiting STAT3 signaling in hepatocellular carcinoma. Issue 11 (23rd September 2021)